- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: (PARP) Ингибиторы
Total 63693 results
-
Lan CoffmanNational Cancer Institute (NCI); MorphoSys AGRecruitingRecurrent Ovarian CancerUnited States
-
M.D. Anderson Cancer CenterRecruitingAdvanced Malignant Solid Neoplasm | Refractory Malignant Solid NeoplasmUnited States
-
zr Pharma & GmbHCompleted
-
National Cancer Institute (NCI)Completed
-
AstraZenecaCompletedPancreatic NeoplasmsUnited States, United Kingdom
-
AstraZenecaKuDOS Pharmaceuticals LimitedCompletedMelanoma NeoplasmsUnited States, United Kingdom
-
AstraZenecaCompleted
-
AbbVieCompletedMetastatic Breast CancerUnited States, Argentina, Australia, Austria, Belarus, Belgium, Canada, Chile, Colombia, Czechia, Denmark, Estonia, Finland, France, Germany, Hungary, Israel, Italy, Korea, Republic of, Latvia, Lithuania, Mexico, Netherlands, Norway, Po... and more
-
University Health Network, TorontoGlaxoSmithKlineRecruitingOvarian Cancer | Fallopian Tube Cancer | Primary Peritoneal Cancer | High Grade Serous Cancer | High Grade Endometrioid CancerCanada
-
AstraZenecaCompletedOvarian Neoplasms | BRCA1 Protein | BRCA2 ProteinNetherlands, Belgium, United Kingdom, Poland
-
Sun Yat-sen UniversityNot yet recruitingOvarian Cancer | Primary Peritoneal Cancer | High Grade Serous Adenocarcinoma of Ovary | High Grade Endometrioid Ovarian Cancer | Fallopian-tube CancerChina
-
Cambridge University Hospitals NHS Foundation TrustAstraZeneca; Cancer Research UKRecruiting
-
Jiangsu HengRui Medicine Co., Ltd.Terminated
-
AbbVieCompletedBreast Cancer | Gastric Cancer | Ovarian Cancer | Lung Cancer | Colon Cancer | Solid TumorsUnited States, Netherlands, Spain
-
AbbVieCompletedNon-squamous Non-small Cell Lung CancerUnited States, Argentina, Australia, Canada, Czechia, Denmark, Finland, Germany, Hungary, Israel, Japan, Korea, Republic of, Netherlands, New Zealand, Russian Federation, South Africa, Spain, Taiwan, Turkey, United Kingdom
-
AstraZenecaActive, not recruitingBreast | Prostate | Ovarian | Pancreatic | Advanced TumoursSweden, Spain, Israel, Australia, Germany
-
zr Pharma & GmbHCompleted
-
National Cancer Institute, SlovakiaCompletedTesticular CancerSlovakia
-
AstraZenecaMerck Sharp & Dohme LLCCompletedMetastatic Castration-resistant Prostate CancerBelgium, France, Italy, Netherlands, Poland, United States, Canada, Czechia, Russian Federation, United Kingdom, Spain
-
AbbVie (prior sponsor, Abbott)CompletedLocally Advanced Rectal CancerUnited States, Australia
-
AbbVieCompletedAdvanced Solid TumorsJapan
-
AstraZenecaRecruitingOvarian Cancer | Lung AdenocarcinomaUnited States, China, Spain, Canada, Australia, Taiwan, Israel, Japan, United Kingdom
-
AbbVie (prior sponsor, Abbott)CompletedGastric CancerUnited States, Korea, Republic of
-
Jiangsu HengRui Medicine Co., Ltd.Peking University Cancer Hospital & InstituteCompletedOvarian Cancer | Triple Negative Breast CancerChina
-
National Cancer Institute (NCI)RecruitingLung Neoplasms | Small Cell Lung Cancer | Prostate Cancer | Urothelial Carcinoma | Urothelial CancerUnited States
-
Fujian Cancer HospitalFujian Provincial HospitalNot yet recruiting
-
Eisai LimitedCompletedOvarian Cancer | Triple Negative Breast Cancer | Malignant Solid Tumour | Advanced Melanoma | B-cell Malignancy, Low-gradeUnited Kingdom
-
University Hospital Southampton NHS Foundation...British Lung Foundation; University of SouthamptonActive, not recruitingMesothelioma, MalignantUnited Kingdom
-
Massachusetts General HospitalPfizerRecruiting
-
Jonsson Comprehensive Cancer CenterMedivation, Inc.; BioMarin Pharmaceutical; Translational Research in OncologyCompletedMetastatic Cancer | Unspecified Adult Solid TumorUnited States
-
Eisai Inc.Completed
-
Cancer Institute and Hospital, Chinese Academy...Beijing Jishuitan HospitalRecruitingSoft Tissue SarcomaChina
-
California Pacific Medical Center Research InstituteM.D. Anderson Cancer CenterRecruitingMetastatic MelanomaUnited States
-
AkesoTerminatedOvarian Neoplasms | Ovarian Cancer | Recurrent Ovarian Carcinoma | Relapsed Ovarian CancerChina
-
National Cancer Institute (NCI)Active, not recruitingMalignant Glioma | Recurrent Childhood Ependymoma | Rhabdoid Tumor | Advanced Malignant Solid Neoplasm | Refractory Malignant Solid Neoplasm | Recurrent Hepatoblastoma | Recurrent Langerhans Cell Histiocytosis | Recurrent Malignant Solid Neoplasm | Recurrent Medulloblastoma | Recurrent Neuroblastoma | Recurrent... and other conditionsUnited States, Puerto Rico
-
AstraZenecaKuDOS Pharmaceuticals LimitedCompleted
-
PfizerCompletedBreast Cancer | Colorectal Cancer | Pancreatic Cancer | Ovarian Cancer | NSCLC | Prostate Cancer | Advanced Solid Tumors | Solid TumorsUnited States, Australia
-
Tesaro, Inc.European Network of Gynaecological Oncological Trial Groups (ENGOT); US Oncology... and other collaboratorsCompletedA Maintenance Study With Niraparib Versus Placebo in Patients With Platinum Sensitive Ovarian CancerOvarian Neoplasms | Platinum Sensitive Ovarian CancerUnited States, Belgium, Sweden, Germany, Israel, Austria, Canada, Denmark, Spain, Italy, United Kingdom, Poland, France, Hungary, Norway
-
National Cancer Institute (NCI)CompletedRecurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma | Breast Carcinoma | Ovarian Carcinoma | Pancreatic Carcinoma | Prostate Carcinoma | Recurrent Breast Carcinoma | Estrogen Receptor Negative | HER2/Neu Negative | Progesterone Receptor Negative | Triple-Negative... and other conditionsUnited States
-
Dana-Farber Cancer InstituteAstraZeneca; National Comprehensive Cancer NetworkActive, not recruitingFatigue | Ovarian Cancer | Coping Behavior | Coping SkillsUnited States
-
SanofiCompleted
-
The University of Texas Health Science Center at...WithdrawnCancer of the Breast
-
AstraZenecaMerck Sharp & Dohme LLC; GOG Foundation; Myriad Genetic Laboratories, Inc.Active, not recruitingAdvanced Ovarian Cancer | Newly Diagnosed | FIGO Stage III-IV | Partial Response | Complete Response | BRCA Mutation | First Line Platinum ChemotherapyKorea, Republic of, France, Italy, United States, Israel, Canada, China, Brazil, United Kingdom, Poland, Australia, Japan, Netherlands, Russian Federation, Spain
-
University College, LondonAstraZeneca; Cancer Research UKActive, not recruitingHead and Neck CancerUnited Kingdom
-
National Cancer Institute (NCI)Active, not recruitingAdvanced Malignant Solid NeoplasmUnited States
-
University of Michigan Rogel Cancer CenterJanssen Scientific Affairs, LLCRecruiting
-
AstraZenecaCompletedOvarian NeoplasmsSpain, United States, Belgium, United Kingdom, Israel, Poland, Germany, Sweden, Australia
-
AbbVie (prior sponsor, Abbott)Completed
-
Heather WachtelRecruitingPheochromocytoma | ParagangliomaUnited States
-
AbbVieGynecologic Oncology Group;Australia New Zealand Gynaecological Oncology...TerminatedOvarian Cancer | Ovarian NeoplasmUnited States, Australia, Brazil, Denmark, Israel, Japan, Korea, Republic of, New Zealand, Poland, Spain, United Kingdom